<DOC>
	<DOC>NCT01178125</DOC>
	<brief_summary>This is an open-label, single treatment study. All subjects will receive 12 months of oral contraceptive therapy with DR-102. Study participants will receive physical and gynecological exams, including Pap smear. During the study, all participants will be required to complete a daily diary.</brief_summary>
	<brief_title>A Study to Evaluate the Efficacy and Safety of DR-102 for the Prevention of Pregnancy</brief_title>
	<detailed_description />
	<mesh_term>Contraceptives, Oral</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<criteria>Sexually active at risk for pregnancy Agreement to use study oral contraceptive therapy as their only method of birth control during the study History of regular spontaneous menstrual cycles or withdrawal bleeding episodes Others as dictated by protocol Any contraindication to the use of oral contraceptives Pregnancy or plans to become pregnant in the next 14 months Smoker and age greater than or equal to 35 years Others as dictated by protocol</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Pregnancy Prevention</keyword>
	<keyword>Oral Contraceptives</keyword>
</DOC>